Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas

G. Manenti, S. Pilotti, F. C. Re, G. Della Porta, M. A. Pierotti

Research output: Contribution to journalArticlepeer-review


A total of 96 tumour samples (88 primary tumours and 8 nodal metastases) from 88 patients with thyroid adenomas and carcinomas were investigated for ras gene mutations using polymerase chain reaction, oligonucleotide probing and sequencing. Neither the 19 adenomas nor the 31 papillary carcinomasan alysed harboured point mutations. In our cases, mutations in all three ras oncogenes were found in follicular carcinomas (five out of 21) and in the less differentiated thyroid tumour: poorly differentiated carcinomas (three out of 11) and undifferentiated carcinomas (one out of five). Finally, mutated ras oncogenes had a significant association with the appearance of haematogenous (particularly bone) metastases, suggesting a role of ras genes activation in the metastatic capability of these tumours.

Original languageEnglish
Pages (from-to)987-993
Number of pages7
JournalEuropean Journal of Cancer
Issue number7
Publication statusPublished - 1994


  • DNA mutational analysis
  • genes
  • neoplasm metastases
  • oligonucleotide probes
  • polymerase chain reaction
  • prognosis
  • ras
  • thyroid neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology


Dive into the research topics of 'Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas'. Together they form a unique fingerprint.

Cite this